MedTrace Logo

Transperineal, MRI-guided, Prostate Biopsy

NCT02651948 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2025-12-19

No results posted yet for this study

Summary

Primary purpose:

Complications and rehospitalizations after transperineal prostate biopsy MRI-guided are reduced than transrectal prostate biopsies.

Secondary purposes:

* Patients tolerance after transperineal prostate biopsy MRI-guided is better than after transrectal prostate biopsies.
* Core of transperineal prostate biopsies are better than core of transrectal prostate biopsies
* Study of correlation between radiologic images and anatomopathologic result
* Description of needle track during the procedure
* Description of real time template saturation prostate biopsy
* Comparison of transperineal prostate biopsy relevance according to EBM
* Comparison of 1.5T MRI and 3T MRI for prostate cancer detection

Conditions

Interventions

PROCEDURE

Transperineal, MRI-guided, prostate biopsy

PROCEDURE

Transrectal prostate biopsy (TRB):

Sponsors & Collaborators

  • University Hospital, Strasbourg, France

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-01
Primary Completion
2023-08-01
Completion
2024-02-01

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02651948 on ClinicalTrials.gov